Targeting DYRK1A with rationally designed pyrazine–guanidine hybrids for Alzheimer's disease: design, synthesis, and biological evaluation

Sabiha Khan, Sumaiya Khan, Shafa Khan, Md. Ataur Rahman, Abdur Rahman, Aquib Reza, Shilpi Khurana, Mohammad Zahid Ashraf, Asimul Islam, Nasimul Hoda